Migraine without aura is the most common type of migraine headache, accounting for about 80% of all migraines. The aim of the present investigation was to determine the neurochemical metabolite alterations in the occipital lobe of patients suffering from migraine without aura using proton magnetic resonance spectroscopy (1H-MRS).
Methods
Fifteen patients suffering from migraine without aura with an occipital plaque and 16 healthy controls were included in this study. Changes in the neurochemical metabolites in the occipital lobe were assessed using 1H-MRS. The ratios of N-acetylaspartate (NAA) to creatine (Cr), choline (Cho) to Cr and myo-inositol (MI) to NAA were measured by voxel volume at 8 cm3.
Results
The mean NAA/Cr ratio decreased significantly in patients compared to controls. Cho/Cr and MI/NAA ratios increased significantly in patients. In addition, the duration of the disease and the frequency of headache attacks were significantly associated with a decrease in the NAA/Cr ratio and an increase in the Cho/Cr ratio.
Conclusions
Migraine without aura shows a significant association with changes in neurochemical metabolites detectable by 1H-MRS in the occipital lobe of patients. In addition, changes in metabolic ratios showed a significant relationship with the duration of the disease and the frequency of headache attacks.
ReyngoudtHDescampsBAchtenE.1H-MRS of brain metabolites in migraine without aura: absolute quantification using the phantom replacement technique. MAGMA2010;
23: 227–241.
4.
RohmannJLRistPMBuringJE, et al.
Migraine, headache, and mortality in women: a cohort study. J Headache Pain2020;
21: 27–29.
5.
Headache Classification Subcommittee of the International Headache Society.The international classification of headache disorders: 2nd edition. Cephalalgia2004;
24: S9–S160.
6.
BigalMELiptonRB.Clinical course in migraine: conceptualizing migraine transformation. Neurology2008;
71: 848–855.
7.
LiPGuHXuJ, et al.
Purkinje cells of vestibulocerebellum play an important role in acute vestibular migraine. J Integr Neurosci2019;
18: 409–414.
8.
NguyenBNVingrysAJMcKendrickAM.The effect of duration post-migraine on visual electrophysiology and visual field performance in people with migraine. Cephalalgia2014;
34: 42–57.
9.
WelchKMLevineSRD’AndreaG, et al.
Brain Ph in migraine: an in vivo phosphorus-31 magnetic resonance spectroscopy study. Cephalalgia1988;
8: 273–277.
10.
CevoliSFavoniVCortelliP.Energy metabolism impairment in migraine. Curr Med Chem2019;
26: 6253–6260.
11.
SarchielliPTarducciRPresciuttiO, et al.
Functional 1H-MRS findings in migraine patients with and without aura assessed interictally. Neuroimage2005;
24: 1025–1031.
12.
GuTMaXXXuYH, et al.
Metabolite concentration ratios in thalami of patients with migraine and trigeminal neuralgia measured with 1H-MRS. Neurol Res2008;
30: 229–233.
13.
AbadNRosenbergJTRousselT, et al.
Metabolic assessment of a migraine model using relaxation-enhanced 1H spectroscopy at ultrahigh field. Magn Reson Med2018;
79: 1266–1275.
14.
SándorPSDydakUSchoenenJ, et al.
MR-spectroscopic imaging during visual stimulation in subgroups of migraine with aura. Cephalalgia2005;
25: 507–518.
15.
YounisSHougaardAVestergaardMB.Migraine and magnetic resonance spectroscopy: a systematic review. Curr Opin Neurol2017;
30: 246–262.
16.
Rościszewska-ŻukowskaIZając-MnichMJanikP.Characteristics and clinical correlates of white matter changes in brain magnetic resonance of migraine females. Neurol Neurochir Pol2018;
52: 695–703.
17.
MohamedREAboelsafaAAAl-MaltAM.Interictal alterations of thalamic metabolic concentration ratios in migraine without aura detected by proton magnetic resonance spectroscopy. Egypt J Radiol Nucl Med2013;
44: 859–870.
18.
DichgansMHerzogJFreilingerT.1H-MRS alterations in the cerebellum of patients with familial hemiplegic migraine type 1. Neurology2005;
64: 608–613.
19.
GuliyevaAApaydinMBeckmannY, et al. Migraine or idiopathic intracranial hypertension: magnetic resonance venography and magnetic resonance imaging findings. Neuroradiol J. Epub ahead of print 22 April 2020. DOI: 10.1177/1971400920919322.
20.
SchwedtTJDodickDW.Advanced neuroimaging of migraine. Lancet Neurol2009;
8: 560–568.
21.
FilippiMMessinaR.The chronic migraine brain: what have we learned from neuroimaging?Front Neurol2020;
10: 1356.
22.
RothrockJFMarKRYakshTL, et al.
Cerebrospinal fluid analyses in migraine patients and controls. Cephalalgia1995;
15: 489–493.
23.
FaghihiRZeinali-RafsanjaniBMosleh-ShiraziMA.Magnetic resonance spectroscopy and its clinical applications: a review. J Med Imaging Radiat Sci2017;
48: 233–253.
24.
VanhammeLSundinTHeckePV, et al.
MR spectroscopy quantitation: a review of time-domain methods. NMR Biomed2001;
14: 233–246.
25.
WeillerCMayALimmrothV, et al.
Brain stem activation in spontaneous human migraine attacks. Nat Med1995;
1: 658–660.
26.
ChakrabortyGMekalaPYahyaD, et al.
Intraneuronal N-acetylaspartate supplies acetyl groups for myelin lipid synthesis: evidence for myelin-associated aspartoacylase. J Neurochem2001;
78: 736–745.
27.
BatesTEStrangwardMKeelanJ, et al.
Inhibition of N-acetylaspartate production: implication for 1H MRS studies in vivo. Neuroreport1996;
7: 1397–1400.
28.
BaslowMHGuilfoyleDN.Effect of N-acetylaspartic acid on the diffusion coefficient of water: a proton magnetic resonance phantom method for measurement of osmolyte-obligated water. Anal Biochem2002;
311: 133–138.
29.
González De La AlejaJRamosAMato-AbadV, et al.
Higher glutamate to glutamine ratios in occipital regions in women with migraine during the interictal state. Headache2013;
53: 365–375.
30.
SchulzUGBlamireAMCorkillRG.Association between cortical metabolite levels and clinical manifestations of migrainous aura: an MR-spectroscopy study. Brain2007;
130: 3102–3110.
31.
ReyngoudtHPaemeleireKDierickxA, et al.
Does visual cortex lactate increase following photic stimulation in migraine without aura patients? A functional 1H-MRS study. J Headache Pain2011;
12: 295–302.
32.
PrescotJBecerraLPendseG.Excitatory neurotransmitters in brain regions in interictal migraine patients. Mol Pain2009;
5: 34–36.
33.
MacrıMGarreffaGGioveF, et al.
Cerebellar metabolite alterations detected in vivo by proton MR spectroscopy. J Magn Reson Imaging2003;
21: 1201–1206.
34.
LaiTHFuhJLLirngJF, et al.
Brainstem 1H-MR spectroscopy in episodic and chronic migraine. J Headache Pain2012;
13: 645–651.
35.
LirngJChenHFuhJ, et al.
Increased myo-inositol level in dorsolateral prefrontal cortex in migraine patients with major depression. Cephalalgia2015;
35: 702–709.
36.
AmbrosiniAGarreffaGColonneseC, et al. Increased cerebellar myo-inositol in migraine with aura on 1H-MRS: An indication of altered CA2+ homeostasis? In: Program and abstracts of the 55th annual meeting of the American Academy of Neurology, Honolulu, Hawaii, 29 March–5 April 2003.
37.
SchmitzNAdmiraal-BehloulFArkinkEB, et al.
Attack frequency and disease duration as indicators for brain damage in migraine. Headache2008;
48: 1044–1055.
38.
BarbiroliBMontagnaPCortelliP, et al.
Abnormal brain and muscle energy metabolism shown by 31P magnetic resonance spectroscopy in patients affected by migraine with aura. Neurology1992;
42: 1209–1214.
